Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection
about
Preclinical evaluation of the HIV-1 fusion inhibitor L'644 as a potential candidate microbicideIn vitro antiviral characteristics of HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068.HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting CellsDendritic cells: active and passive players in therapy of human diseases.
P2860
Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection
@ast
Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection
@en
Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection
@nl
type
label
Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection
@ast
Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection
@en
Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection
@nl
prefLabel
Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection
@ast
Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection
@en
Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection
@nl
P2860
P1476
Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection
@en
P2093
Ines Frank
Melissa Robbiani
P2860
P304
P356
10.1097/QAI.0B013E3181FF2AA5
P407
P577
2011-03-01T00:00:00Z